University of Cambridge
Also, a new AI-driven genomics platform developed in Queensland can identify cancer biomarkers and predict tumour responses to chemotherapy.
The UK study will enable earlier identification of infection and develop research for treatment.
The game has now been licensed through the University of Cambridge's technology transfer arm to app developer Peak.